These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing, reported early 2004-000404-40 A double blind, randomised, placebo-controlled study to investigate chronic intermittent ''pulse'' therapy of moxifloxacin as a prevention of acute exacerbation in out-patients with chronic bronchitis not-yet-due
Ongoing, reported early 2004-000725-30 A phase II, multi-centre, open-label, uncontrolled study to evaluate the efficacy and safety of BAY 43-9006 given daily in combination with repeated 21-day cycles of dacarbazine (DTIC) chemotherapy in... not-yet-due
Completed, but no date, and reported results 2004-001083-43 Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients with acute symptomatic Deep Vein Thrombosis ODIXa-DVT A prospective, randomized, multinational, multicenter, partially blinded, parallel-group, ... bad-data
Ongoing, reported early 2004-001341-14 Controlled, double-blind, randomized, dose-rangig study of once-daily regimen of BAY 59-7939 in the prevention of VTE in patients undergoing elective total hip replacement - ODIXaHIP-OD study not-yet-due
Ongoing, reported early 2004-001770-40 A randomized controlled study of BAY 43-9006 in combination with doxorubicin versus doxorubicin in patients with advanced hepatocellular carcinoma. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-001773-26 A Phase III randomised, placebo-controlled study of sorafenib in patients with advanced hepatocellular carcinoma 2008-11-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002171-16 Once-daily oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis. The EINSTEIN-DVT dose-finding study 2005-12-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002172-42 A randomized, double-blind, double-dummy, multicenter, parallel group study to compare the tolerability and efficacy of once daily vardenafil versus vardenafil PRN versus placebo in men immediately af... 2007-12-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002291-42 Multi-center, open, randomized, dose finding phase II study to investigate for a maximum of three years ultra low dose levonorgestrel contraceptive intrauterine systems (LCS) releasing in vitro 12 µg/... 2008-12-09 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-005079-40 Placebo and active controlled, double dummy phase II study to prove efficacy of Aspirin (1000 mg solid dose) in treatment of acute low back pain. 2006-12-19 bad-data
Ongoing, reported early 2004-005282-37 Double-blind, cross-over, placebo-controlled pilot study to characterize the profile of those patients with traumatic spinal cord injury diagnosed by electrophysiological, urodynamic and clinical (ASI... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-000544-86 A randomised, open-label, multi-center phase II study of first-line treatment with BAY 43-9006 (Sorafenib) versus standard treatment with Interferon alpha-2a in patients with unresectable and/or metas... 2010-06-23 bad-data
Reported results 2005-000586-19 Phase-II study to investigate the efficacy and safety of ZK 219477 as second-line therapy in patients with Stage IIIB or Stage IV non-small-cell lung cancer (NSCLC) 2009-04-15 due-trials
Reported results 2005-001678-28 A randomized, explorative, double-blind, double-dummy, multi-center, parallel group study to assess sustainable efficacy of once daily vardenafil (10 mg) for 12 and 24 weeks versus vardenafil PRN in m... 2007-03-20 due-trials
Completed, but no date, and reported results 2005-001720-36 A pivotal, placebo controlled, phaseIII study to compare efficacy and tollerability of a fixed combination, containing 500 mg ASA and 30 mg Pseudoephedrine, in comparison to its single components in p... bad-data
Listed as ongoing, but also has a completion date and reported results 2005-001727-11 A phase III, open-label, prospective, two-armed, multicenter, randomized, group sequential study to evaluate the efficacy and safety of subsequent treatment with the Zevalin (ibritumomab tiuxetan) stu... 2008-12-05 bad-data
Reported results 2005-002125-32 A multicenter, open, randomized, parallel-group comparison to assess the safety and efficacy of the oral contraceptive SH T 00186 D (0.02 mg ethinylestradiol as betadex clathrate and 3 mg drospirenone... 2008-10-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-002524-34 An open label, non comparative, phase III study of the Raf Kinase Inhibitor BAY 43-9006 as a subsequent to first line therapy in patients with advanced renal cell carcinoma. 2008-11-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002757-45 A prospective controlled study on the effect on bleeding events and joint function in young adults with severe hemophilia A after a 6 month prophylaxis treatment compared to on demand treatment 2008-03-25 bad-data
Completed, but no date, and reported results 2005-002779-34 Prospective, multicenter, randomized, double blind, parallel arm study to evaluate the efficacy and safety of Moxifloxacin 400 mg OD for 7 days versus amoxicillin clavulanate/claritromycin for 10 days... bad-data
Reported results 2005-002796-32 A randomized, double-blind, placebo-controlled, multi-center, parallel group study to assess the efficacy of vardenafil in the treatment of symtomatic Benign Prostatic Hyperplasia 2006-06-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-003216-30 Ensayo clínico de fase II prospectivo, multicéntrico, aleatorizado de grupos paralelos, abierto, para estudiar la eficacia, seguridad y tolerabilidad de 2 dosis de ZK 219477 (16 y 12 mg/m2 de área de ... 2009-01-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003999-38 A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fus... 2007-01-25 bad-data
Reported results 2005-004055-35 A multi-center, randomized, double blind, placebo controlled study to investigate the efficacy and safety of Aprotinin on transfusion requirements in patients with bladder cancer undergoing radical or... 2007-01-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-004340-32 A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, 7 Cycle Duration (196 Days), Phase 3 Study of Oral Estradiol Valerate/Dienogest Tablets for the Treatment of Dysfunctional ... 2008-05-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-004351-35 Ensayo clínico controlado, doble ciego y aleatorizado de BAY 59-7939 en la prevención del tromboembolismo venoso en pacientes con cirugía electiva de sustitución total de cadera. Estudio RECORD 1 2007-03-13 bad-data
Reported results 2005-004473-14 Proof of concept study to investigate the impact of BAY 58-2667 given intravenously in patients with acute decompensated chronic congestive heart failure 2007-05-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-004620-40 Ensayo clínico controlado, doble ciego y aleatorizado de BAY 59-7939 en la prevención del tromboembolismo venoso en sujetos con cirugía electiva de sustitución total de rodilla. Estudio RECORD 3 2007-04-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-004689-18 A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Surgical Procedures... 2007-01-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-004691-20 RECORD 2 Study: REgulation of Coagulation in ORthopedic Surgery to prevent DVT and PE, controlled, Double-Blind, Randomized Study of BAY59-7939 in the Extended Prevention of VTE in Patients Undergoing... 2007-05-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005245-19 A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel plus or minus Sorafenib BAY 43-9006 in chemonaive patients with Stage IIIB-IV Non-Small Cell Lung Cancer NS... 2008-08-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005581-36 Estudio fase II aleatorizado para investigar la eficacia, seguridad y tolerabilidad de ZK 230211 (100 mg frente a 25 mg) como tratamiento endocrino de segunda línea en mujeres posmenopáusicas con cánc... 2011-03-21 bad-data
Completed, reported early 2006-000067-29 Phase I/II study to investigate the safety, tolerability, efficacy and pharmacokinetics of ZK 219477 in combination with cisplatin as first-line therapy in chemotherapy-naive patients with extensive-d... 2009-08-17 not-yet-due
Reported results 2006-000394-30 Multicenter study to investigate the bleeding profile and the insertion easiness in women inserted with a second consecutive MIRENA for contraception or menorrhagia 2012-10-18 due-trials
Reported results 2006-000463-29 Evaluation of vardenafil for the treatment of subjective tinnitus: A controlled pilot study 2007-09-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-000874-56 A prospective, randomized, double dummy, double blind, multi-center trial comparing the safety and efficacy of moxifloxacin 400 mg IV QD 24 hours to that of ertapenem 1.0 g IV QD 24 hours for 5 to 14 ... 2009-03-25 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001228-37 A randomized, double blind, parallel group study of vardenafil flexible dose versus placebo in males with erectile dysfunction and their female partners’ sexual quality of life. PARTNER II 2007-08-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001599-18 A prospective, randomized, double dummy, double blind, multinational, multicenter trial comparing the safety and efficacy of sequential intravenous/oral moxifloxacin 400 mg once daily to intravenous... 2018-06-12 bad-data
Reported results 2006-002361-39 A 4-week, open-label, multicenter, urodynamic pilot study to explore the efficacy, tolerability and safety of darifenacin (7.5 mg with up-titration to 15 mg) in patients with multiple sclerosis and ne... 2007-09-21 due-trials
Reported results 2006-002402-60 RECORD 4 Study: REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE; a controlled, double-blind, randomized study of BAY 59-7939 in the prevention of VTE in subjects undergoing elect... 2008-05-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-002688-26 A Phase III. randomized, double-blind, placebo controlled trial comparing the efficacy of gemcitabine, cisplatin and sorafenib to gemcitabine, cisplatin, and placebo in first-line treatment of patient... 2011-06-14 bad-data
Completed, reported early 2006-003520-10 A multicenter, non-randomized, non-blinded, non-controlled study to investigate the impact of multiple doses of BAY 63 2521 on safety, tolerability, pharmacokinetics, and pharmacodynamics in patients ... 2014-09-12 not-yet-due
Completed, reported early 2006-003622-29 Estudio ARRIVE (Aspirin to Reduce Risk of Initial Vascular Events, aspirina para reducir el riesgo de accidentes vasculares iniciales) – Estudio aleatorizado, doble ciego, controlado con placebo, mult... 2017-11-15 not-yet-due
Completed, reported early 2006-004153-22 Open-label multi-center study of magnetic resonance imaging (MRI) with 0.1 mmol/kg BW Gadovist (1.0 M) to assess pharmacokinetics, safety and tolerability in children 2008-06-04 not-yet-due
Reported results 2006-004397-27 Multi-center, double-blind, placebo-controlled study to investigate the efficacy and safety of daily oral 100 mg dehydroepiandrosterone (DHEA) over 6 treatment cycles as a concomitant therapy to oral ... 2009-04-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-004449-40 A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Escalation and Dose-Confirmation Study to Evaluate the Safety and Efficacy of Rivaroxaban in Combination with Aspirin Alone or with As... 2008-10-22 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004458-26 Randomized, comparative, open label treatment with double-blind placebo-controlled periods within treatment study to evaluate the efficacy and safety of a once-a-week prophylaxis treatment with BAY 79... 2007-06-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004494-96 Once-daily oral direct factor Xa inhibitor rivaroxaban in the long-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis or pulmonary emboli... 2009-09-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004495-13 Oral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism. 2011-12-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004595-13 A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter, Event-Driven, Non-inferiority Study Comparing the Efficacy and Safety of Once Daily Oral Rivaroxaban (BAY 59-7939) W... 2010-10-08 bad-data
Reported results 2006-004633-15 A randomized, double-blind, parallel group prospective pilot study to assess the effect of vardenafil on clinical outcome and on procedure duration after green light laser-ablation of the prostate gla... 2009-04-24 due-trials
Reported results 2006-004899-13 A multi-center, open-label, randomized, controlled, parallel-group study to assess efficacy and safety of an extended flexible regimen of the combined oral contraceptive SH T00186D (0.02 mg ethinylest... 2009-12-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-005145-11 Estudio aleatorizado, doble ciego, controlado con placebo, de grupos paralelos con una dosis de 10 mg de vardenafilo dos veces al día para evaluar el efecto en la prueba urodinámica en pacientes con v... 2008-11-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005270-47 Estudio internacional, multicéntrico, de fase IIIb, sobre el tratamiento en días alternos de pacientes con Esclerosis Múltiple Recidivante con: (Fase A) Betaseron/Betaferon 250 µg ó 500 µg de forma do... 2008-06-17 bad-data
Reported results 2006-005508-14 A randomized, , double-blind, single centre, intra-individual comparison study with repeated application to assess the wound-healing efficacy of a 5 % Dexpanthenol ointment compared with placebo in pa... 2007-04-23 due-trials
Reported results 2006-006199-39 A double-blind, randomized, multi-center study to investigate the endometrial safety of a continuous, combined, oral estrogen/progestin preparation (0.5 mg 17β-estradiol [E2] / 0.25 mg drospire... 2009-08-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-006436-22 A multicenter Study Evaluating the Efficacy of Nifedipine GITS ヨ Telmisartan Combination in Blood Pressure Control and Beyond: comparison of two strategies. 2009-11-06 bad-data
Reported results 2006-006633-41 Monocenter, open-label, randomized study to determine the ovulation inhibitory effect of the combined oral contraceptives SH T04769G (0.015 mg Ethinylestradiol and 1.5 mg Dienogest in a modified relea... 2008-06-03 due-trials
Ongoing, reported early 2006-006673-24 Etude pilote multicentrique de phase IV, en ouvert, randomisée, en groupe parallèles destinée à évaluer l'éfficacité d'un protocole de rééducation fonctionnelle des patients atteints d'une forme récur... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-000072-16 Ensayo clínico, multinacional, multicéntrico, aleatorizado ,doble ciego, controlado con placebo, para evaluar la eficacia y la seguridad de BAY 63-2521 (1 mg, 1.5 mg, 2mg, o 2.5 mg,tid), administrado ... 2012-07-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000420-40 Multi-center, open-label, randomized study to assess the safety and contraceptive efficacy of two doses (in vitro 12 µg/24 h and 16 µg/24 h) of the ultra low dose levonorgestrel contraceptive intraute... 2013-06-03 bad-data
Ongoing, reported early 2007-000425-22 Phase IIa Efficacy and Safety Trial of capadenoson in Patients with Chronic Stable Angina not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-000583-25 A randomized, double masked, active controlled, phase 3 study of the efficacy, safety, and tolerability of repeated doses of intravitreal VEGF Trap-Eye in subjects with neovascular age-related macular... 2011-08-11 bad-data
Completed, but no date, and reported results 2007-001320-12 A national, prospective, randomized, open label study to asses the efficacy and safety of IV/PO moxifloxacin vs IV ceftriaxone + IV azithromicin followed by PO amoxicilline/clavulanate and PO claritr... bad-data
Completed, but no date, and reported results 2007-001491-36 ''A prospective, randomized, open label, active comparator, multicenter, national trial to compare the efficacy and safety of sequential IV/PO moxifloxacin 400 mg once daily versus IV amoxicillin/clav... bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001791-36 A double-blind, randomized, placebo and active controlled, multicenter study to investigate efficacy and safety after oral administration of 2 and 3 mg ZK 283197, 1 mg 17ß-estradiol and placebo once d... 2009-02-11 bad-data
Reported results 2007-002256-42 An open-label, non-randomized, multi-center study to optimize image assessment and evaluate the efficacy and safety of BAY 94-9172 (ZK 6013443) positron emission tomography (PET) for detection/exclusi... 2010-11-30 due-trials
Ongoing, reported early 2007-002365-13 Sorafenib as adjuvant to radioiodine therapy in non-medullary thyroid carcinoma not-yet-due
Ongoing 2007-002604-17 Programa de extensión a largo plazo con sorafenib not-yet-due
Completed, reported early 2007-002912-24 Study to evaluate the safety and pharmacokinetics of ciprofloxacin following inhalation of ciprofloxacin dry powder for inhalation administered to pediatric patients with cystic fibrosis aged 12-17 ye... 2008-07-07 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-003059-36 Estudio aleatorizado, doble ciego, controlado con placebo, multicéntrico y multinacional de fase IIb para evaluar la eficacia y la tolerabilidad de BAY 58 2667 administrado por vía intravenosa en paci... 2009-03-26 bad-data
Reported results 2007-003619-30 Study to investigate the effect of the A1 agonist capadenoson on ventricular HR in patients with persistent or permanent atrial fibrillation by administration of capadenoson in a dose of 4 mg once dai... 2009-03-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-003718-32 Ensayo clínico, controlado , doble ciego, paralelo, para evaluar la eficacia y seguridad del tratamiento profiláctico con BAY 79-4980 administrado una vez por semana, comparado con el tratamiento con ... 2010-10-05 bad-data
Ongoing 2007-003928-37 A multicenter, non-randomized, non-blinded, non-controlled study to investigate the impact of multiple doses of BAY 63-2521 on safety, tolerability, pharmacokinetics and pharmacodynamics in patients w... not-yet-due
Reported results 2007-004544-73 A double-blind, randomized, uncontrolled study to evaluate inhibition of ovulation of two oral estradiol / drospirenone regimens in healthy young female volunteers over a period of 3 treatment cycles 2009-01-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-004614-14 MAGELLAN - Estudio Multicéntrico, Aleatorizado, de Grupos paralelos, para evaluar la superioridad de la Eficacia de rivaroxabAN frente enoxaparina en la profilaxis de sujetos médicos hospitalizados. 2010-11-24 bad-data
Reported results 2007-004746-33 A multicenter, randomized, double-blind, crossover, phase 3 study to determine the safety and efficacy of gadobutrol 1.0 molar (Gadovist®) in patients referred for contrast-enhanced MRI of the central... 2009-04-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-004875-21 A Phase II, Multi-centre, Open-label Study to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of Intrapatient Dose Escalation of Sorafenib as First Line Treatment for Metastatic Renal C... 2011-01-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005083-28 A Phase II, Randomized, Open-label, MultiCenter, Study Evaluating the Efficacy of SOrafenib AloNe and Sorafenib in Combination with Low DosE InterfeRon Alpha-2a as Second-line Treatment of Sunitinib F... 2009-06-26 bad-data
Reported results 2007-005163-94 A prospective, randomized, verum controlled, open label, parallel group multi-center phase III clinical trial to demonstrate the superiority of 500 or 250 mg Aspirin® i.v. (BAY 81-8781) treatment vers... 2014-06-03 due-trials
Reported results 2007-005258-22 A multi-center, double-blind, randomized, parallel-group study to evaluate cycle control and safety of 6 different regimens of an oral contraceptive containing estradiol and drospirenone in healthy fe... 2009-07-23 due-trials
Completed, but no date, and reported results 2007-005693-31 Contrast-enhanced MRI examination of cerebral neoplastic enhancing lesions: comparison of diagnostic efficacy of Gd-DOTA 0.5 M and gadobutrol 1.0 M at 0.1 mmol Gd/kg body weight: Intra-individual com... bad-data
Reported results 2007-006096-37 A prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the tre... 2011-03-04 due-trials
Ongoing 2008-000107-28 A Phase II uncontrolled study of BAY 73-4506 (DAST) in previously untreated patients with metastatic or unresectable renal cell cancer (RCC) not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-000536-40 Ensayo pivotal de fase III para determinar la eficacia y la seguridad del comprimido bucodispersable de vardenafilo comparado con placebo en el tratamiento de hombres con disfunción eréctil (DE) – ens... 2009-01-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-000583-16 Multi-center, randomized comparison study to eVALUatE outcomes and resource needs of imaging and treatment following Primovist-enhanced MRI of the liver in comparison to extra-cellular con... 2010-12-31 bad-data
Reported results 2008-000718-63 An investigator-blinded, active-controlled phase 3 study to prove the non-inferior efficacy of a Clotrimazole ovule (500 mg) versus a Clotrimazole vaginal tablet (500 mg) in vaginal candidiasis 2009-06-29 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-000879-26 ”Double-blind, randomized phase II study to Evaluate the safety and efficacy of Acetyl-l-carnitine in the prevention of Sagopilone-induced peripheral Neuropathy” 2010-08-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-000906-35 A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of BAY 41-6551 as Adjunctive Therapy in Intubated and Mechanically-Ventilated Patient... 2017-11-10 bad-data
Reported results 2008-000985-21 Randomized, controlled, parallel, prospective trial to evaluate the effect of secondary prophylaxis with rFVIII therapy in severe hemophilia A adult and/or adolescent subjects, as applicable, compared... 2013-11-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-001087-36 A Phase III randomized, double-blind, placebo-controlled study of sorafenib as adjuvant treatment for hepatocellular carcinoma after surgical resection or local ablation. 2014-11-28 bad-data
Reported results 2008-001198-13 Multicenter, open-label, randomized, uncontrolled study to evaluate inhibition of ovulation of two transdermal patch formulations containing 0.55 mg ethinylestradiol and either 1.05 or 2.1 mg gestoden... 2009-02-19 due-trials
Reported results 2008-001494-15 Phase I/II Study of Sagopilone in combination with carboplatin and bevacizumab in the first-line treatment of patients with stage IIIB/IV, non-squamous NSCLC. 2008-12-04 due-trials
Reported results 2008-002053-20 A 54 week treatment, randomized, multi center, double blind, placebo controlled study to assess the safety and efficacy of NEBIDO 1000 mg (4 ml) in elderly men with symptomatic late onset hypogonadism... 2008-10-13 due-trials
Reported results 2008-002069-30 A randomized, double-blind, single centre, placebo-controlled pilot study to assess on a molecular level the influence of a 5 % dexpanthenol ointment in subjects with previously injured skin by invest... 2009-02-27 due-trials
Reported results 2008-002140-41 Double-blind, placebo controlled, randomized study of vardenafil to determine efficacy on Erectile Dysfunction (ED) in men with ED and Metabolic Syndrome ("ED-METABOLIC") 2009-10-08 due-trials
Reported results 2008-002263-13 Multi-center, double-blind, randomized study to investigate the impact of a sequential oral contraceptive containing estradiol valerate and dienogest (SH T00658ID) compared to a monophasic contracepti... 2010-07-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-003215-13 A double-blind, randomized, multicenter, placebo-controlled phase 3 trial to prove the superiority of bifonazole vs. placebo after 4 weeks of onychomycosis treatment (as a follow-up of a 2 weeks treat... 2010-01-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-003226-42 A multicenter, randomized, double-blind, active-controlled, parallel group, 2-arm study to investigate the effect of estradiol valerate/dienogest compared to Microgynon on hormone withdrawal associate... 2010-12-28 bad-data
Reported results 2008-003303-31 The Einstein CYP cohort study. Oral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism using a strong CYP 3A4 inducer 2011-06-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-003482-68 Ensayo clínico, multinacional, multicéntrico, aleatorizado ,doble ciego, controlado con placebo, para evaluar la eficacia y la seguridad de BAY 63-2521 (1 mg, 1.5 mg, 2mg, o 2.5 mg ,tid )administrado ... 2012-05-14 bad-data
Listed as ongoing, but also has a completion date 2008-003539-19 Estudio de extensión a largo plazo, multicéntrico y multinacional, para evaluar la seguridad y tolerabilidad de BAY 63 2521 (1 mg, 1,5 mg, 2 mg o 2,5 mg tid) administrado por vía oral, en pacientes co... 2016-06-27 bad-data
Listed as ongoing, but also has a completion date 2008-003610-94 Estudio de extensión a largo plazo, multicéntrico y multinacional, para evaluar la seguridad y tolerabilidad de BAY 63 2521 (1 mg, 1,5 mg, 2 mg o 2,5 mg tid) administrado por vía oral, en pacientes co... 2015-05-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004214-27 Estudio multicéntrico, abierto, no controlado para investigar la eficacia y seguridad del parche anticonceptivo transdérmico que contiene 0,55 mg de etinilestradiol y 2,1 mg de gestodeno (n.º de mater... 2011-09-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004429-41 A Double-Blind, Randomized Phase II Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Ovarian Epithelial Cancer or Primary Peritoneal Cancer Patients who have achieved a Com... 2012-12-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004496-22 Prospective non-randomized (pharmacoepidemiologic) cohort study (open-label, multicenter) to assess the magnitude of potential risk with the administration of Gadovist® in patients with moderate to se... 2015-05-28 bad-data
Reported results 2008-005025-11 A Phase 2b, Double Blind, Randomized Study Evaluating the Efficacy and Safety of Sorafenib Compared With Placebo When Administered in Combination With Chemotherapy (Modified FOLFOX6) for the Treatment... 2012-02-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-005056-24 A Phase II randomized, double-blind, placebo-controlled study of sorafenib or placebo in combination with transarterial chemoembolisation (TACE) performed with DC Bead and doxorubicin for intermediate... 2013-02-08 bad-data
Reported results 2008-005625-11 A multi-center, double-blind, double-dummy, randomized, controlled, parallel-group study to assess efficacy and safety of SH T00658ID compared to SH D593B in the treatment of primary dysmenorrhea 2010-11-18 due-trials
Reported results 2008-005654-21 An investigator-blind, randomized, multicenter, 5-arm, placebo- and active controlled parallel group pilot trial to explore the efficacy and tolerability of topical bifonazole liquid spray in patients... 2010-05-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-005867-33 Prospective non-randomized (pharmacoepidemiologic) cohort study (open-label, multicenter) to assess the magnitude of potential risk with the administration of Primovist/Eovist in patients with moderat... 2013-07-24 bad-data
Listed as ongoing, but also has a completion date 2008-006021-14 A Phase III randomized, placebo controlled, double blind trial of Sorafenib plus Erlotinib vs. Sorafenib plus placebo as First Line systemic treatment for Hepatocellular Carcinoma (HCC) 2018-05-23 bad-data
Reported results 2008-006022-34 Randomized phase II study of sorafenib plus bicaluamide vs. placebo plus bicalutamide in castration-resistant asymptomatic or mildly symptomatic metastatic prostate cancer patients who had orchiectomy... 2008-12-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-006914-62 A Phase III, multi-center, placebo controlled trial of Sorafenib (BAY 43-9006) in patients with relapsed or refractory advanced predominantly non squamous Non-Small Cell Lung Cancer (NSCLC) after 2 or... 2013-04-02 bad-data
Reported results 2008-007024-26 A single-center, open-label, crossover, randomized study to investigate the impact of the transdermal contraceptive patch containing 0.55 mg ethinylestradiol and 2.1 mg gestogene (material no. 8087639... 2011-05-09 due-trials
Reported results 2008-007308-27 Multi-center, open-label, randomized, parallel-group comparison of cycle control, bleeding pattern, lipid and carbohydrate metabolism of the transdermal contraceptive patch containing 0.55 mg ethinyle... 2010-09-03 due-trials
Reported results 2008-008314-40 Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and efficacy of inhaled ciprofloxacin compared to placebo in subjects with cystic fibrosis 2011-01-26 due-trials
Reported results 2009-009177-10 Multicenter, open-label, randomized study to evaluate inhibition of ovulation of two transdermal patch formulations containing 0.55 mg ethinylestradiol and either 1.05 or 2.1 mg gestodene in healthy y... 2011-08-23 due-trials
Reported results 2009-009597-27 An open label, multi-center, phase 3 study with corresponding blinded image reading to determine the efficacy and safety of a single intravenous injection of 0.1 mmol/kg body weight of gadobutrol 1.0 ... 2012-03-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-009598-90 An open label, multi-center, phase 3 study with corresponding blinded image reading to determine the efficacy and safety of a single intravenous injection of 0.1 mmol/kg body weight of gadobutrol 1.0 ... 2013-09-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-009869-34 Randomized, placebo-controlled, double-blind, multi center study to evaluate the safety and efficacy of ciprofloxacin inhale compared to placebo in patients with non-cystic fibrosis bronchiectasis 2010-09-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-010147-14 A diagnostic interventional, controlled, cross-sectional evaluation of joint status using MRI in subjects with severe hemophilia A treated with primary prophylaxis, secondary prophylaxis, or on-demand... 2010-12-31 bad-data
Reported results 2009-010599-45 Single-center, open-label, uncontrolled study to investigate the effects of the transdermal contraceptive patch containing 0.55 mg ethinylestradiol and 2.1 mg gestodene (material no. 80876395) on the ... 2011-06-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-010973-19 A randomized, double-masked, sham-controlled phase 3 study of the efficacy, safety, and tolerability of repeated intravitreal administration of VEGF Trap-Eye in subjects with macular edema secondary t... 2012-02-01 bad-data
Ongoing, reported early 2009-011355-46 A double blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of acetylsalicylic acid combined with pseudoephedrine, compared with acetylsalicylic acid alone, and pseud... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-012007-25 A Double-Blind, Randomized Phase III Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer 2017-08-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012149-43 A two part randomized, cross-over, open-label trial to evaluate the pharmacokinetics, efficacy, and safety profile of plasma-protein free recombinant FVIII formulated with sucrose (BAY 81-8973) in pr... 2013-03-14 bad-data
Reported results 2009-012150-20 A phase II/III, randomized, cross-over, open-label trial to demonstrate superiority of prophylaxis over on-demand therapy in previously treated subjects with severe hemophilia A treated with plasma pr... 2012-12-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-012569-79 An open-label, non-randomized study to evaluate the efficacy and safety of BAY 94-9172 (ZK 6013443) positron emission tomography (PET) imaging for detection/exclusion of cerebral ß-amyloid when compar... 2014-09-18 bad-data
Reported results 2009-012570-13 An uncontrolled open label multicenter phase II safety study of BAY 73-4506 in patients with hepatocellular carcinoma (HCC) 2013-03-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-012787-14 A randomized, double-blind, placebo-controlled phase III study of regorafenib plus BSC versus placebo plus BSC in patients with metastatic colorectal cancer (CRC) who have progressed after standard t... 2014-01-22 bad-data
Reported results 2009-013081-17 Open-label, multi-center, two-stage, age stratified, pharmacokinetic, safety, and efficacy study in children 2 month to < 2 years of age undergoing Magnevist Injection enhanced MRI 2010-09-09 due-trials
Reported results 2009-014377-40 A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of BAY 58-2667 (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously t... 2011-02-04 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-014378-16 A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of Low Dose BAY 58-2667 (25 μg/h, 10 μg/h) Given Intravenously to ... 2011-03-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-014911-11 A multi-centre, randomized, double-blind, active control, parallel-group, 2-arm study to investigate the effect of ethinylestradiol / drospirenone / (0.02 mg/3 mg) oral contraception in a 24/4 regimen... 2011-10-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-015578-37 A randomized, double-blind, multicenter trial to evaluate the safety and efficacy of sequential (intravenous, oral) moxifloxacin versus comparator in pediatric subjects with complicated intra-abdomina... 2015-01-21 bad-data
Ongoing 2009-015878-35 Randomized, double blind, placebo controlled, parallel group, multi-center study to evaluate the hemodynamic effects of Riociguat (BAY 63-2521) as well as safety and kinetics in patients with pulmonar... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-017077-37 A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose- Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients with Essenti... 2012-05-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-017082-39 A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of BAY 58-2667 (50 µg/h, 100 µg/h, 150 µg/h) Given Intravenously t... 2011-02-04 bad-data
Reported results 2009-017139-16 Effect of exercise alone or in combination with testosterone replacement on muscle strength and quality of life in older men with low testosterone concentrations: a randomized double-blind, placebo co... 2011-07-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-017169-53 A multi-center, open label, single-arm study to investigate the safety and efficacy of daily oral administration of 2 mg dienogest tablets for the treatment of endometriosis in adolescents over a tre... 2014-06-02 bad-data
Reported results 2009-017313-30 Single-dose pilot study of oral rivaroxaban in pediatric subjects with venous thromboembolism 2015-07-07 due-trials
Ongoing 2009-017957-37 A randomized, double-blind, placebo-controlled phase III study of regorafenib plus best supportive care versus placebo plus best supportive care for subjects with metastatic and/or unresectable gastro... not-yet-due
Reported results 2010-018436-41 Acute hemoDynamic effects of RIociguat (BAY 63-2521) in patients with puLmonary hypertension Associated with diasTolic heart failurE (DILATE 1): A randomized, double-blind, placebo-controlled, single... 2012-10-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-018501-10 A Phase III Randomized, Double blind, Placebo-controlled Trial Comparing Capecitabine Plus Sorafenib Versus Capecitabine Plus Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative B... 2018-10-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-018863-40 An interaction study to evaluate changes in blood pressure following 1, 1.5, 2, and 2.5 mg riociguat tid (dose titration) compared to placebo treatment on the background of stable sildenafil pretreatm... 2013-05-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-019588-12 A multi-center, phase I/II study of BAY 86-9766 in combination with gemcitabine in patients with locally advanced inoperable or metastatic pancreatic cancer 2013-08-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-019902-17 A multicenter, open-label, randomized, controlled, two-arm study to assess compliance with daily tablet intake of women on treatment with the oral contraceptive SH T00186D/BAY 86-5300 (0.02 mg ethinyl... 2012-08-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-020121-41 An uncontrolled, open-label, phase II study in subjects with metastatic adenocarcinoma of the colon or rectum who are receiving first line chemotherapy with mFOLFOX6 (oxaliplatin/ folinic acid/5-fluor... 2014-06-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-020122-18 A prospective, randomized, double-blind, double-dummy, placebo- and active controlled, multicenter study assessing the efficacy and safety of the combination BAY 60 4552 / vardenafil compared to varde... 2011-05-31 bad-data
Reported results 2010-020181-21 Multicenter, randomized, open-label, parallel-group study to evaluate user satisfaction with and tolerability of the low-dose levonorgestrel (LNG) intrauterine delivery system (IUS) with 12 µg LNG/day... 2014-05-28 due-trials
Reported results 2010-020922-16 International, prospective, double-blind, 3-arm comparative, randomized, placebo controlled phase IV study on the effect of counseling and either tranexamic acid or mefenamic acid or placebo, on the m... 2011-12-22 due-trials
Reported results 2010-021195-28 Single-center, randomized, placebo-controlled, double-blind, parallel group study to evaluate whether a single-dose of either 20 mg piroxicam, 40 mg piroxicam or 80 mg piroxicam shows an effect on ov... 2012-05-29 due-trials
Reported results 2010-021255-81 Multicenter, open-label, randomized study to evaluate inhibition of ovulation during treatment with three transdermal patch formulations containing 0.55 mg ethinylestradiol (EE) and 2.10 mg gestodene... 2011-10-06 due-trials
Ongoing 2010-021781-29 A multicenter Phase III uncontrolled open-label trial to evaluate safety and efficacy of BAY 81-8973 in children with severe haemophilia A under prophylaxis therapy not-yet-due
Reported results 2010-022364-12 A randomized, double masked, active controlled, phase III study of the efficacy and safety of repeated doses of intravitreal VEGF Trap-Eye in subjects with diabetic macular edema 2015-03-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-023001-36 Multicenter, open-label study to evaluate the safety and efficacy (by blinded reading) of contrast-enhanced magnetic resonance angiography (MRA) after a single intravenous injection of 0.1 mmol/kg gad... 2014-05-28 bad-data
Reported results 2010-023002-13 Multicenter, open-label study to evaluate the safety and efficacy (by blinded reading) of Gadobutrol-enhanced magnetic resonance angiography (MRA) after a single injection of 0.1 mmol/kg of Gadobutrol... 2012-07-12 due-trials
Reported results 2010-023003-96 Open-label, multicenter, pharmacokinetic, and safety study in children (term newborn infants to 23 months of age) undergoing a contrast-enhanced MRI with an intravenous injection of 0.1 mmol/kg BW gad... 2013-12-17 due-trials
Completed, but no date 2010-023586-22 Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) bad-data
Listed as ongoing, but also has a completion date and reported results 2010-023911-32 Multicenter, open-label, randomized, controlled parallel-group study to assess discontinuation rates, bleeding patterns, user satisfaction and adverse event profile of LCS12 in comparison to etonogest... 2015-04-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-024332-42 A randomized, double-blind, placebo-controlled phase II study to investigate the efficacy and safety of riociguat (0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg and 2.5 mg TID) in patients with symptomatic pulmonary... 2016-09-14 bad-data
Reported results 2011-000301-45 A randomized, double-blind, multi-center study to assess safety and tolerability of different oral doses of BAY 94-8862 in subjects with stable chronic heart failure with left ventricular systolic dys... 2012-06-12 due-trials
Reported results 2011-000323-33 A Phase 2/3, multicenter, open-label clinical study to assess the safety and efficacy of BAY86-6150 in subjects with hemophilia A or B with inhibitors, composed of 2 Parts (A & B). Part A: Sequential ... 2013-04-30 due-trials
Reported results 2011-001094-58 Prospective, multi-center, randomized, heparin-controlled dose-finding trial to evaluate the efficacy and safety of rivaroxaban, a direct factor Xa inhibitor, on the background of standard dual antipl... 2013-03-04 due-trials
Reported results 2011-001893-24 Relative bioavailability and food effect study of two oral liquid formulations in comparison to a 1mg tablet of riociguat to characterize its pharmacokinetic properties in healthy male and female adul... 2012-05-12 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-002065-37 Multi-center, single-arm study to assess the safety, efficacy, discontinuation rate and pharmacokinetics of the low-dose levonorgestrel intrauterine contraceptive system (LCS12) in post-menarcheal fem... 2015-05-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-002234-39 A prospective, randomized, open-label, parallel-group, active-controlled, multicenter study exploring the efficacy and safety of once-daily oral rivaroxaban (BAY 59-7939) compared with that of dose-ad... 2014-01-24 bad-data
Completed, reported early 2011-004155-39 Phase Ib / II study of BAY 1000394 in combination with cisplatin / etoposide or carboplatin / etoposide as first-line therapy in subjects with extensive disease small cell lung cancer 2016-03-08 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-004208-39 Randomized, double-blind, placebo-controlled, multicEnter Study comParing CIprofloxacin DPI 32.5 mg BID intermittently administered for 28 days on / 28 days off or 14 days on / 14 days off versus plac... 2016-03-09 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-004539-30 30-day, open-label, active-controlled, randomized study of the safety, efficacy and the pharmacokinetic and pharmacodynamic properties of oral rivaroxaban in children with various manifestations of ve... 2016-09-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-005210-11 A Phase II/III, multicenter, partially randomized, open label trial investigating safety and efficacy of on-demand and prophylactic treatment with BAY 94-9027 in Severe Hemophilia A 2016-04-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-005836-25 An open-label phase IIIb study of regorafenib in patients with metastatic colorectal cancer (CRC) who have progressed after standard therapy 2015-01-02 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-000075-16 Radium-223 Chloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients with Bone Metastasis 2016-02-28 bad-data
No trial status on register 2012-000737-40 Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients bad-data
No trial status on register 2012-000952-32 Open-label, multi-center study to evaluate the safety, efficacy, and plasma gadolinium concentrations after an intravenous injection of 0.1 mL/kg body weight Eovist/Primovist for enhanced magnetic res... bad-data
Reported results 2012-001062-15 An open-label, international, multicenter, interventional study exploring the efficacy of once-daily oral rivaroxaban (BAY 59-7939) for the treatment of left atrial/left atrial appendage thrombus in s... 2014-12-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-002104-40 An open-label phase IIIb study of riociguat in patients with in-operable CTEPH, or recurrent or persisting PH after surgical treatment who are not satisfactorily treated and cannot participate in any... 2015-12-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-002563-10 Multicenter open-label study to evaluate efficacy of gadobutrol-enhanced cardiac magnetic resonance imaging (CMRI) for detection of significant coronary artery disease (CAD) in subjects with known or ... 2017-08-31 bad-data
Ongoing 2012-002602-52 Open-label, uncontrolled Phase II trial of intravenous PI3K inhibitor BAY 80-6946 in patients with relapsed, indolent or aggressive Non-Hodgkin’s lymphomas not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-002627-15 A randomized, double-blind, double-dummy, multi-center study to assess safety and efficacy of BAY 94-8862 in subjects with emergency presentation at the hospital because of worsening chronic heart fai... 2014-12-09 bad-data
Ongoing, reported early 2012-003649-14 A randomized, double blind, placebo-controlled, multicenter phase III study of regorafenib in patients with hepatocellular carcinoma (HCC) after sorafenib not-yet-due
Ongoing 2012-003650-88 A randomized, open-label, active-controlled, Phase II study of intravenous anetumab ravtansine (BAY 94-9343) or vinorelbine in patients with advanced or metastatic malignant pleural mesothelioma overe... not-yet-due
Reported results 2012-003763-22 A combined Phase IIa / IIb study of the efficacy, safety, and tolerability of repeated topical doses of regorafenib eye drops, in treatment-naïve subjects with neovascular age related macular degenera... 2015-07-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-004179-38 A randomized, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of different oral doses of BAY 94-8862 in subjects with type 2 diabetes mellitus and the clinical d... 2014-08-07 bad-data
Ongoing 2012-004180-43 A randomized controlled trial of rivaroxaban for the prevention of major cardiovascular events in patients with coronary or peripheral artery disease (COMPASS - Cardiovascular OutcoMes for People usin... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-004369-42 A Randomized, Double-blind, Placebo-controlled Phase-III Study of Adjuvant Regorafenib Versus Placebo for Patients with Stage IV Colorectal Cancer After Curative Treatment of Liver Metastases 2016-09-28 bad-data
Ongoing, reported early 2012-004434-42 A multi-center, phase III, non-controlled, open-label trial to evaluate the pharmacokinetics, safety, and efficacy of BAY 94-9027 for prophylaxis and treatment of bleeding in previously treated childr... not-yet-due
Ongoing, reported early 2012-004491-18 A Phase IIa, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Safety and Efficacy of 28 Day Oral Administration of BAY 85-8501 in Patients with non-Cystic Fibrosis Bron... not-yet-due
Listed as ongoing, but also has a completion date 2012-004493-26 A Multicenter, Randomized, Double-Blind, Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination Taken Orally for 8 Weeks in Adult Subje... 2016-09-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-004515-32 Multicenter, Open-Label, Long-Term Safety and Efficacy Study of the Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Adult Subjects with Moderate t... 2014-05-01 bad-data
Not reported 2012-004857-10 A Multicenter, Randomized, Double-Blind, Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination Taken Orally for 8 Weeks in Adult Subje... 2016-09-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-005262-35 BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with first... 2014-06-18 bad-data
Ongoing 2013-000120-33 An open-label, randomized, active-controlled, parallel-group, Phase-3b study of the efficacy, safety, and tolerability of 2 mg aflibercept administered by intravitreal injections using two different t... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2013-000241-39 A prospective, single-arm, multicenter, uncontrolled, open-label Phase II trial of refametinib (BAY 86-9766) in combination with sorafenib as first line treatment in patients with RAS mutant Hepatocel... 2017-03-13 bad-data
Reported results 2013-000311-25 A prospective, single-arm, multicenter, uncontrolled, open-label Phase II trial of refametinib (BAY 86-9766) in patients with RAS mutant Hepatocellular Carcinoma (HCC) 2014-10-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-000619-26 Reduced-dosed rivaroxaban and standard-dosed rivaroxaban versus ASA in the long-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis and/or... 2016-11-04 bad-data
Listed as ongoing, but also has a completion date 2013-000768-27 Multicenter, randomized, double-blind, double-dummy, active-comparator, event-driven, superiority phase III study of secondary prevention of stroke and prevention of systemic embolism in patients with... 2018-02-15 bad-data
Completed, reported early 2013-001048-73 A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of BAY 41-6551 as Adjunctive Therapy in Intubated and Mechanically-Ventilated Patient... 2017-11-10 not-yet-due
Reported results 2013-001190-24 A controlled, parallel group, open-label, multicenter extension study to investigate efficacy and safety of oral BAY 85-3934 and darbepoetin alfa comparator in the long term treatment of anemia in pre... 2016-12-16 due-trials
Reported results 2013-001192-21 A randomized, parallel group, open-label, multicenter study to investigate the efficacy and safety of oral BAY 85-3934 and active comparator (darbepoetin alfa) in the maintenance treatment of anemia i... 2015-11-23 due-trials
Reported results 2013-001193-14 A randomized, placebo-controlled, double-blind, parallel group, multicenter study to investigate the efficacy and safety of 5 fixed doses of BAY 85-3934 administered orally in the correction of anemia... 2015-10-23 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-001759-10 An open-label, international, multicenter, single-arm, uncontrolled, phase IIIb study of riociguat in patients with pulmonary arterial hypertension (PAH) who demonstrate an insufficient response to tr... 2016-12-29 bad-data
Reported results 2013-001899-38 Single dose, double-blind, placebo-controlled, single center, randomized cross-over study to investigate safety, tolerability, pharmacodynamics and pharmacokinetic properties of BAY 63-2521 after oral... 2014-11-07 due-trials
Reported results 2013-002287-11 A randomized parallel-group, placebo-controlled, double-blind, multi-center dose finding phase II trial exploring the pharmacodynamic effects, safety and tolerability, and pharmacokinetics of four dos... 2015-06-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-002288-25 A randomized parallel-group, placebo-controlled, double-blind, multi-center dose finding phase II trial exploring the pharmacodynamic effects, safety and tolerability, and pharmacokinetics of four dos... 2015-09-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-002522-23 A double blinded, placebo controlled, study to investigate the safety, tolerability, pharmacokinetics and acute cardiovascular responses of a 7 day oral treatment with the partial adenosine A1 recepto... 2015-04-02 bad-data
Completed, reported early 2013-002783-12 A multi-center, open-label, randomized cross-over study to compare the acute tolerability and pharmacokinetics of BAY Q 6256 (iloprost; Ventavis) inhalation using the I-Neb nebulizer and the FOX nebul... 2017-09-29 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2013-003046-17 A re-treatment safety study of radium-223 dichloride in subjects with castration-resistant prostate cancer with bone metastases who received an initial course of six doses of radium-223 dichloride 50 ... 2017-04-12 bad-data
Listed as ongoing, but also has a completion date 2013-003118-42 A three arm randomized, open-label Phase II study of radium-223 dichloride 50 kBq/kg (55 kBq/kg after implementation of NIST update) versus 80 kBq/kg (88 kBq/kg after implementation of NIST update), a... 2018-08-09 bad-data
Ongoing 2013-003438-33 A phase III randomized, double-blind, placebo-controlled trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone in the treatment of asymptomatic or mildly s... not-yet-due
Other 2013-003579-36 A multi-center, open-label, non-randomized, phase I dose escalation study of regorafenib (BAY 73-4506) in pediatric subjects with solid malignant tumors that are recurrent or refractory to standard th... not-yet-due
Ongoing 2013-003820-36 A MULTINATIONAL, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, not-yet-due
Ongoing 2013-003893-29 A Phase III, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin’s l... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2013-003945-40 A randomized, parallel-group, double-blind, placebo-controlled, multi-center study to assess the efficacy and safety of different doses of BAY 1002670 in subjects with uterine fibroids over 3 months 2016-05-05 bad-data
Reported results 2013-003980-74 Multi-center, randomized, comparator-controlled, single-blind, parallel-group study to investigate the pharmacodynamics, pharmacokinetics and safety of an intrauterine system releasing BAY 1007626, as... 2016-05-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-004198-28 A randomized, double blind, placebo-controlled, multicenter phase II study to evaluate efficacy and safety of roniciclib in subjects with extensive-stage disease small cell lung cancer (SCLC) who are ... 2016-05-25 bad-data
Reported results 2013-004464-54 A randomized, double-masked, sham-controlled phase 3b/4 study of the efficacy, safety, and tolerability of intravitreal aflibercept monotherapy compared to aflibercept with adjunctive photodynamic the... 2017-07-07 due-trials
Reported results 2013-004595-35 Multi-center phase 2 study to assess the safety, tolerability and early signs of efficacy of tid orally administered BAY63-2521 in adult deltaF508 homozygous Cystic Fibrosis patients 2017-08-31 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-004659-19 Randomized, double-blind, placebo-controlled, multicenter study comparing Ciprofloxacin DPI 32.5 mg BID intermittently administered for 28 days on / 28 days off or 14 days on / 14 days off versus plac... 2016-10-19 bad-data
Ongoing 2013-004768-72 A randomized, double-blind, parallel-group, multicenter Phase 2b study to assess the efficacy and safety of two different doses of vilaprisan (BAY 1002670) versus placebo in women with symptomatic end... not-yet-due
Reported results 2013-005090-53 A randomized, double-blind, double-dummy, parallel- group, multi-center phase IIb study to assess the efficacy and safety of different dose combinations of an aromatase inhibitor and a progestin in an... 2016-10-24 due-trials
Listed as ongoing, but also has a completion date 2014-000565-47 Multicenter, open-label, active-controlled, randomized study to evaluate the efficacy and safety of an age-and body weight-adjusted rivaroxaban regimen compared to standard of care in children with ac... 2017-04-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2014-000566-22 30-day, open-label, active-controlled, randomized study of the safety, efficacy and the 2017-05-04 bad-data
Ongoing 2014-000925-19 A randomized, double-blind Phase III study of copanlisib versus placebo in patients with rituximab-refractory indolent non-Hodgkin’s lymphoma (iNHL) - CHRONOS-2 not-yet-due
Ongoing 2014-001353-16 A Randomised, Double-Blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of Riociguat in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc) not-yet-due
No trial status on register 2014-001362-10 Routine prophylaxis treatment versus On-demand treatment for Children with severe Hemophilia A: comparison of all bleeding events in Chinese Hemophilia patients bad-data
Ongoing 2014-002113-39 A phase II randomized, double-blind, placebo-controlled trial of radium-223 dichloride versus placebo when administered to metastatic HER2 negative hormone receptor positive breast cancer subjects wit... not-yet-due
Ongoing 2014-002114-23 A phase II randomized, double-blind, placebo-controlled trial of radium-223 dichloride in combination with exemestane and everolimus versus placebo in combination with exemestane and everolimus when a... not-yet-due
Completed, reported early 2014-002385-74 7-day study of the safety, efficacy and the pharmacokinetic and pharmacodynamic properties of oral rivaroxaban in children from birth to less than 6 months with arterial or venous thrombosis. 2017-12-18 not-yet-due
Ongoing 2014-002407-25 A Phase 4 long-term follow-up study to define the safety profile of radium-223 dichloride not-yet-due
Ongoing 2014-003132-39 Managing neovascular age-related macular degeneration (nAMD) over 2 years with a Treat and Extend (T&E) regimen of 2 mg intravitreal (IVT) aflibercept - a randomized, open-label, active-controlled, pa... not-yet-due
Ongoing 2014-003193-17 A multi center, single arm, interventional Phase 4 study to evaluate a Treat and Extend regimen of intravitreal aflibercept for treatment of macular edema secondary to central retinal vein occlusion not-yet-due
Other 2014-003952-29 Open-label, individual dose titration study to evaluate safety, tolerability and pharmacokinetics of riociguat in children from 6 to less than 18 years of age with pulmonary arterial hypertension (PAH... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2014-004221-41 A randomized, parallel-group, double-blind placebo-controlled and open label active-controlled, multi-center study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids 2016-10-28 bad-data
No trial status on register 2014-004612-10 A multicenter, double-blind, randomized, placebo controlled study to evaluate the efficacy and safety of an oral contraceptive preparation YAZ (drospirenone 3 mg / ethinylestradiol 20 µg) for 6 treatm... bad-data
No trial status on register 2014-004613-93 Open label study to evaluate the effect, safety and tolerability of 250µg (8 MIU) interferon beta 1b (Betaferon) given subcutaneously every other day (for 24 weeks) in patients of Chinese origin with ... bad-data
No trial status on register 2014-004622-18 A prospective, open-label, non-randomized, naturalistic, long-term safety surveillance, observational study of either ciprofloxacin (either as oral suspension, oral tablets or sequential IV followed b... bad-data
Listed as ongoing, but also has a completion date 2014-004848-36 An open-label, single-arm Phase II study in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) to evaluate efficacy and safety of treatment with single agent copanlisib and the... 2018-01-19 bad-data
Ongoing 2014-004938-25 An open-label, randomized, active-controlled, parallel-group, Phase-3b study of the efficacy, safety, and tolerability of three different treatment regimens of 2 mg aflibercept administered by intravi... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2014-005119-17 Open-label Phase-4 study to examine the change of vision-related quality of life in subjects with diabetic macular edema (DME) during treatment with intravitreal injections of 2 mg aflibercept accordi... 2017-08-09 bad-data
No trial status on register 2014-005253-39 A Prospective Study to Evaluate the Effect of rFVIII-FS in Different Prophylactic Regimens on Bleeding Events Frequency and Development of Arthropathy in Previously Treated and Minimally Treated Hemop... bad-data
No trial status on register 2014-005268-13 An Open Label, Actual Use Study in Consumers Taking an Extended-Release Over the Counter NSAID in a Naturalistic Setting bad-data
No trial status on register 2014-005269-66 A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Trial Assessing the Analgesic Efficacy of a Single, Oral Dose of an Extended Release Naproxen Sodium Tablet in Postsurgical Dental... bad-data
No trial status on register 2014-005270-11 Comparative Onset of Action of a Fast Release Aspirin Tablet in a Dental Impaction Pain Model bad-data
No trial status on register 2014-005271-81 A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Trial Assessing the Analgesic Efficacy of a Single, Oral Dose of a Fast Release Aspirin 1000 mg in Postsurgical Dental Pain bad-data
No trial status on register 2014-005272-28 A Randomized, Double-Blind, Placebo Controlled Trial to Assess the Analgesic Efficacy and Safety of Extended Release Naproxen Sodium Tablets in Postsurgical Dental Pain bad-data
No trial status on register 2014-005278-12 A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Trial Assessing the Analgesic Efficacy of a Single, Oral Dose of a Fast Release Aspirin 650 mg in Postsurgical Dental Pain bad-data
Reported results 2014-005297-12 A single blind, multicenter pilot study to investigate the safety and tolerability of a 14 day oral treatment with different doses of the chymase inhibitor BAY 1142524 in comparison to placebo in clin... 2016-03-04 due-trials
No trial status on register 2014-005305-20 A Pilot Self Selection Trial of an Extended-Release Over-the-Counter Analgesic bad-data
No trial status on register 2014-005316-41 An Actual Use Trial In A Simulated OTC Environment of an Extended-Release Over-the-Counter NSAID bad-data
Ongoing 2014-005569-58 An international, multicenter, randomized, double-blind, placebo-controlled phase 3 trial investigating the efficacy and safety of Rivaroxaban to reduce the risk of major thrombotic vascular events i... not-yet-due
Ongoing 2015-000950-39 A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbid... not-yet-due
Listed as ongoing, but also has a completion date 2015-000962-76 Single-dose study testing a rivaroxaban dry powder formulation for oral suspension in children from 6 months to 12 years with previous thrombosis 2018-05-22 bad-data
Ongoing 2015-000990-11 A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the ... not-yet-due
Ongoing 2015-001088-38 A Phase III, randomized, double-blind, controlled, multicenter study of intravenous PI3K inhibitor copanlisib in combinatione with standard immunochemiotherapy versus standard immunochemotherapy in pa... not-yet-due
Listed as ongoing, but also has a completion date 2015-001975-30 Global multicenter, open-label, randomized, event-driven, active-controlled study comparing a rivAroxaban-based antithrombotic strategy to an antipLatelet-based strategy after transcatheter aortIc vaL... 2018-10-22 bad-data
Listed as ongoing, but also has a completion date 2015-002168-17 A multicenter, randomized, double-blind, double-dummy, parallel-group, active-controlled study to evaluate the efficacy and safety of finerenone compared to eplerenone on morbidity and mortality in pa... 2016-05-11 bad-data
Ongoing 2015-002590-38 A randomized, double-blind, placebo-controlled Phase III study of darolutamide (ODM-201) versus placebo in addition to standard androgen deprivation therapy and docetaxel in patients with metastatic h... not-yet-due
Ongoing 2015-003799-63 A randomized, single blind, threefold crossover, single center study to assess the safety and the effects of 1 mg and 5 mg BAY 1193397 in comparison to placebo on skin capillary blood flow and transcu... not-yet-due
Ongoing 2016-001067-36 A prospective, randomized, international, multicenter, double-arm, controlled, open-label study of Riociguat in patients with pulmonary arterial hypertension (PAH) who are on a stable dose of phosphod... not-yet-due
Completed, report not yet due 2016-002167-33 A randomized, double-blind multicenter study to assess the safety and efficacy of a six month oral treatment with the chymase inhibitor BAY 1142524 at a dose of 25 mg BID in comparison to placebo on t... 2018-09-04 not-yet-due
Ongoing 2016-002438-58 A phase 1b/2 trial to evaluate the safety and efficacy of radium-223 dichloride (BAY 88-8223) in combination with bortezomib and dexamethasone in early relapsed multiple myeloma not-yet-due
Listed as ongoing, but also has a completion date 2016-002681-31 A randomized, active-comparator-controlled, multicenter study to assess the safety and efficacy of different doses of BAY 1213790 for the prevention of venous thromboembolism in patients undergoing el... 2018-06-05 bad-data
Reported results 2016-002813-24 Relative bioavailability study to investigate the pharmacokinetics, safety and tolerability of a single oral dose of finerenone 20 mg as suspension (pediatric formulation), intact tablet and crushed t... 2017-03-01 due-trials
Other 2016-002855-48 A randomized, parallel-group, double-blind, double-dummy, active-controlled, multicenter study to assess the efficacy and safety of vilaprisan in subjects with uterine fibroids not-yet-due
Reported results 2016-002895-29 Relative bioavailability study to investigate the pharmacokinetics, safety 2017-03-17 due-trials
Ongoing 2016-003561-26 A randomized, parallel-group, double-blind and placebo-controlled, multicenter study to assess the efficacy and safety of vilaprisan in subjects with uterine fibroids not-yet-due
Listed as ongoing, but also has a completion date 2016-003839-38 A multicenter, randomized, placebo-controlled, parallel group, double blind, dose-finding Phase II trial to study the efficacy, safety, pharmacokinetic and pharmacodynamic effects of the oral partial ... 2018-05-16 bad-data
Listed as ongoing, but also has a completion date 2016-004062-26 A multicenter, randomized, placebo-controlled, parallel group, double blind, dose-finding Phase II trial to study the efficacy, safety, pharmacokinetic and pharmacodynamic effects of the oral partial ... 2018-07-20 bad-data
Ongoing 2016-004340-11 A randomized, open label, multicenter Phase 2/3 study to evaluate the efficacy and safety of rogaratinib (BAY 1163877) compared to chemotherapy in patients with FGFR-positive locally advanced or metas... not-yet-due
Ongoing 2016-004484-39 An open-label, first-in-human, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and maximum tolerated dose and / or recommended Phase II dose of the ATR ... not-yet-due
Ongoing 2016-004822-41 An open-label, parallel-group, randomized, multicenter study to assess the safety and efficacy of vilaprisan in subjects with uterine fibroids versus standard of care not-yet-due
Listed as ongoing, but also has a completion date 2017-000244-18 A randomized, placebo-controlled, double-blind, parallel-group, multi-center, exploratory dose-response study to assess the efficacy and safety of different oral doses of BAY 1128688 in women with sym... 2018-10-22 bad-data
Completed, reported early 2017-000609-18 Single-dose, open-label, randomized, 2-way crossover bioequivalence study of 20 mg granules for oral suspension rivaroxaban versus 20 mg tablets rivaroxaban under fed condition in healthy subjects 2017-10-27 not-yet-due
Completed, reported early 2017-000648-16 Single-dose, open-label, randomized, 2-way crossover bioequivalence study of 10 mg granules for oral suspension rivaroxaban versus 10 mg tablets rivaroxaban under fasted condition in healthy subjects 2017-10-27 not-yet-due
Ongoing 2017-000656-26 A randomized, double-blind, multicenter study to assess the efficacy and safety of a 6 month oral treatment with the chymase inhibitor BAY 1142524 at a dose of 25 mg BID in comparison to placebo on to... not-yet-due
Completed, report not yet due 2017-001176-31 BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies 2018-05-24 not-yet-due
Ongoing 2017-001483-38 An international, multicenter, Phase 1b/2 study of rogaratinib (BAY 1163877) in combination with atezolizumab as first-line treatment in cisplatin-ineligible patients with FGFR-positive locally advanc... not-yet-due
Ongoing 2017-001851-29 Randomized, multi-center, double-blind, placebo-controlled, group-comparison study to investigate safety, tolerability and pharmacodynamics of BAY2253651 after administration of a single nasal dose in... not-yet-due
Ongoing 2017-002997-38 A randomized, parallel-group, double-blind and open-label, placebo-controlled, multicenter study to assess the efficacy and safety of vilaprisan in subjects with uterine fibroids not-yet-due
Ongoing 2017-003324-67 Multiple escalating dose study of BAY 1093884 in adults with hemophilia A or B with or without inhibitors not-yet-due
No trial status on register 2017-005049-67 A Randomized, Double-Blind, Placebo-Controlled Trial to Compare the Duration of Analgesic Efficacy and Safety of Naproxen Sodium Tablets and Ibuprofen Tablets in Postsurgical Dental Pain bad-data
Ongoing 2018-000128-33 Multi-center, randomized, comparator-controlled, single-blind, parallel-group study to investigate the pharmacodynamics, pharmacokinetics and safety of an intrauterine system (BAY 987443) with three d... not-yet-due
Ongoing 2018-000298-65 A randomized parallel-group, placebo-controlled, double-blind, multi-center trial to eValuate the effIcacy and safeTy of the orAL sGC stImulator vericiguaT to improve phYsical functioning in activitie... not-yet-due